Synthetic Cannabinoids Market Growth: U.S. Therapeutic and Adult-Use Drivers Converge
The Synthetic Cannabinoids Market growth in the U.S. is driven by a convergence of therapeutic demand, wellness consumer interest and regulatory evolution. Demand for new treatments in chronic pain, chemotherapy side-effects, neurology and appetite disorders is rising, while adult consumers seek functional health solutions that traditional over-the-counter products don’t fully address....
0 Σχόλια 0 Μοιράστηκε 36 Views 0 Προεπισκόπηση